Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 980

1.

Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimization.

Anan K, Masui M, Tazawa A, Tomida M, Haga Y, Kume M, Yamamoto S, Shinohara S, Tsuji H, Shimada S, Yagi S, Hasebe N, Kai H.

Bioorg Med Chem Lett. 2019 Feb 15. pii: S0960-894X(19)30091-5. doi: 10.1016/j.bmcl.2019.02.017. [Epub ahead of print]

PMID:
30833109
2.

The impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated.

Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S.

Am J Transplant. 2019 Mar 4. doi: 10.1111/ajt.15337. [Epub ahead of print]

PMID:
30830721
3.

Total phenolic and flavonoid contents and antioxidant activity of ginger (Zingiber officinale Rosc.) rhizome, callus and callus treated with some elicitors.

Ali AMA, El-Nour MEM, Yagi SM.

J Genet Eng Biotechnol. 2018 Dec;16(2):677-682. doi: 10.1016/j.jgeb.2018.03.003. Epub 2018 Mar 21.

4.

Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compounds.

Tobinaga H, Kameyama T, Asahi K, Horiguchi T, Oohara M, Tada Y, Fuchino K, Jikihara S, Endoh T, Kurihara N, Kanda Y, Ogawa M, Tamura N, Yagi S, Taniguchi E, Takahara Y, Shimada S, Takeyama C, Yamamoto S, Shinohara S, Kai H.

Bioorg Med Chem Lett. 2019 Mar 1;29(5):688-693. doi: 10.1016/j.bmcl.2019.01.039. Epub 2019 Feb 1.

PMID:
30728111
5.

Safety and Toxicity of Recombinant Methioninase and Polyethylene Glycol (PEG) Recombinant Methioninase in Primates.

Hoffman RM, Yang Z, Tan Y, Han Q, Li S, Yagi S.

Methods Mol Biol. 2019;1866:211-229. doi: 10.1007/978-1-4939-8796-2_16.

PMID:
30725418
6.

Development of Recombinant Methioninase for Cancer Treatment.

Hoffman RM, Tan Y, Li S, Han Q, Yagi S, Takakura T, Takimoto A, Inagaki K, Kudou D.

Methods Mol Biol. 2019;1866:107-131. doi: 10.1007/978-1-4939-8796-2_10.

PMID:
30725412
7.

Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.

Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

Hepatol Res. 2019 Jan 30. doi: 10.1111/hepr.13320. [Epub ahead of print]

PMID:
30698359
8.

Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.

Takahashi C, Hattori Y, Yagi S, Murai T, Takai C, Ogawa N, Tanemura M, Fuji M, Kawashima Y, Yamamoto H.

Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:78-83. doi: 10.1016/j.msec.2018.11.079. Epub 2018 Nov 30.

PMID:
30678968
9.

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study.

Ueda D, Yoshizawa A, Kaneshiro M, Hirata Y, Yagi S, Hata K, Okajima H, Egawa H, Uemoto S.

Transplant Direct. 2018 Dec 27;5(1):e420. doi: 10.1097/TXD.0000000000000858. eCollection 2019 Jan.

10.

Crude extracts of Sesamum Indicum roots used as anthraquinone source effect on pulping with sodium hydroxide of Sudanese bagasse.

Shomeina SK, Elzaki OT, Yagi S, Mohieldin SD, Khider TO.

BMC Res Notes. 2019 Jan 15;12(1):26. doi: 10.1186/s13104-019-4075-9.

11.

Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.

Yagi S, Nishiyama S, Abe T, Sata M.

BMJ Case Rep. 2019 Jan 10;12(1). pii: bcr-2018-227663. doi: 10.1136/bcr-2018-227663.

PMID:
30635311
12.

Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies.

Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S.

Clin Nutr. 2018 Dec 17. pii: S0261-5614(18)32570-6. doi: 10.1016/j.clnu.2018.12.004. [Epub ahead of print]

PMID:
30595376
13.

Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma.

Ogawa K, Kaido T, Okajima H, Fujimoto Y, Yoshizawa A, Yagi S, Hori T, Iida T, Takada Y, Uemoto S.

J Hepatobiliary Pancreat Sci. 2019 Feb;26(2):73-81. doi: 10.1002/jhbp.602. Epub 2019 Jan 21.

PMID:
30561147
14.

Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction.

Yamamoto K, Kurata Y, Inoue Y, Adachi M, Tsuneto M, Miake J, Ogino K, Ninomiya H, Yoshida A, Shirayoshi Y, Suyama Y, Yagi S, Nishimura M, Yamamoto K, Hisatome I.

Regen Ther. 2018 Sep 19;9:79-88. doi: 10.1016/j.reth.2018.08.005. eCollection 2018 Dec.

15.

Henoch-Schönlein Purpura After Living Donor Liver Transplantation: Report of the First Case.

Aliyev V, Yagi S, Hammad A, Badawy A, Taura K, Okajima H, Takaori K, Kaido T, Uemoto S.

Transplant Proc. 2018 Dec;50(10):4050-4052. doi: 10.1016/j.transproceed.2018.02.072. Epub 2018 Mar 9.

PMID:
30522857
16.

Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kamo N, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Uemoto S.

Clin Nutr. 2018 Sep 28. pii: S0261-5614(18)32457-9. doi: 10.1016/j.clnu.2018.09.019. [Epub ahead of print]

PMID:
30482562
17.

Left atrial functional response after a marathon in healthy amateur volunteers.

Hirata Y, Kusunose K, Yamada H, Morita S, Torii Y, Nishio S, Zheng R, Saijo Y, Fukuda D, Yagi S, Soeki T, Sata M.

Int J Cardiovasc Imaging. 2018 Nov 23. doi: 10.1007/s10554-018-1502-2. [Epub ahead of print]

PMID:
30470971
18.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2018 Nov 22. doi: 10.1007/s10120-018-0900-4. [Epub ahead of print]

PMID:
30467737
19.

Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.

Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.

PMID:
30465085
20.

Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.

Nishimoto S, Aini K, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2018 Oct 16;5:144. doi: 10.3389/fcvm.2018.00144. eCollection 2018.

21.

Simultaneous Pulmonary Arterial and Venous Round Structures in Pulmonary Aspergillosis.

Yagi S, Yamazaki H, Nishio S, Kusunose K, Yamada H, Sata M.

Circ J. 2018 Nov 3. doi: 10.1253/circj.CJ-18-0898. [Epub ahead of print] No abstract available.

22.

Influence of lipopolysaccharide on diazepam-modified loss of righting reflex duration by pentobarbital treatment in mice.

Kitamura Y, Hongo S, Yamashita Y, Yagi S, Otsuki K, Miki A, Okada A, Ushio S, Esumi S, Sendo T.

Eur J Pharmacol. 2019 Jan 5;842:231-238. doi: 10.1016/j.ejphar.2018.10.049. Epub 2018 Nov 2.

PMID:
30391741
23.

Publisher Correction: Experimental Zika Virus Infection in the Pregnant Common Marmoset Induces Spontaneous Fetal Loss and Neurodevelopmental Abnormalities.

Seferovic M, Sánchez-San Martín C, Tardif SD, Rutherford J, Castro ECC, Li T, Hodara VL, Parodi LM, Giavedoni L, Layne-Colon D, Tamhankar M, Yagi S, Martyn C, Reyes K, Suter MA, Aagaard KM, Chiu CY, Patterson JL.

Sci Rep. 2018 Oct 26;8(1):16131. doi: 10.1038/s41598-018-34068-5.

24.

Effects of aging, high-fat diet, and testosterone treatment on neural and metabolic outcomes in male brown Norway rats.

Moser VA, Christensen A, Liu J, Zhou A, Yagi S, Beam CR, Galea L, Pike CJ.

Neurobiol Aging. 2019 Jan;73:145-160. doi: 10.1016/j.neurobiolaging.2018.09.016. Epub 2018 Sep 22.

PMID:
30359877
25.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2018 Oct 17. doi: 10.1007/s10120-018-0887-x. [Epub ahead of print] Erratum in: Gastric Cancer. 2018 Nov 22;:.

PMID:
30328533
26.

Genome Sequences of Rhinovirus Genotype C56 Detected in Three Patients with Acute Respiratory Illness, California, 2016 to 2017.

Pan CY, Yagi S, Padilla T, Fei Fan Ng T, Marine RL, Nix WA, Wadford DA.

Microbiol Resour Announc. 2018;7(7). pii: e00982-18. doi: 10.1128/MRA.00982-18. Epub 2018 Aug 23.

27.

Crystal structure of 3,6-dihy-droxy-4,5-di-methyl-benzene-1,2-dicarbaldehyde.

Yamazaki S, Nishiyama K, Yagi S, Haraguchi T, Akitsu T.

Acta Crystallogr E Crystallogr Commun. 2018 Sep 14;74(Pt 10):1424-1426. doi: 10.1107/S2056989018012495. eCollection 2018 Oct 1.

28.

Crystal structure of (E)-3-[(2,6-di-methyl-phen-yl)diazen-yl]-7-methyl-1H-indazole.

Yagi S, Haraguchi T, Akitsu T.

Acta Crystallogr E Crystallogr Commun. 2018 Sep 14;74(Pt 10):1421-1423. doi: 10.1107/S2056989018012483. eCollection 2018 Oct 1.

29.

<Editors' Choice> Effect of postoperative doxorubicin administration on ischemic wound healing.

Morishita T, Toriyama K, Takanari K, Yagi S, Ebisawa K, Hishida M, Narita Y, Osaga S, Nishida Y, Kamei Y.

Nagoya J Med Sci. 2018 Aug;80(3):357-366. doi: 10.18999/nagjms.80.3.357.

30.

Sex differences in hippocampal cognition and neurogenesis.

Yagi S, Galea LAM.

Neuropsychopharmacology. 2019 Jan;44(1):200-213. doi: 10.1038/s41386-018-0208-4. Epub 2018 Sep 7. Review.

PMID:
30214058
31.

Use of Fat Grafts for Stabilizing Microvascular Pedicle Geometry in Lower Limb Reconstruction.

Yagi S, Suyama Y, Yamaga K, Morita M, Fukuoka K.

Plast Reconstr Surg Glob Open. 2018 Jul 13;6(7):e1799. doi: 10.1097/GOX.0000000000001799. eCollection 2018 Jul. No abstract available.

32.

Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure.

Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

Can J Cardiol. 2018 Oct;34(10):1307-1315. doi: 10.1016/j.cjca.2018.06.003. Epub 2018 Jun 7.

PMID:
30146462
33.

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M.

J Atheroscler Thromb. 2019 Mar 1;26(3):272-281. doi: 10.5551/jat.44735. Epub 2018 Aug 21.

34.

Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation.

Yao S, Yagi S, Nagao M, Uozumi R, Iida T, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Okumura S, Hamaguchi Y, Masano Y, Kaido T, Okajima H, Uemoto S.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1973-1982. doi: 10.1007/s10096-018-3333-4. Epub 2018 Jul 23.

PMID:
30039291
35.

A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure.

Saijo Y, Yamada H, Kusunose K, Bando M, Nishio S, Torii Y, Hirata Y, Seno H, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Echocardiography. 2018 Oct;35(10):1587-1595. doi: 10.1111/echo.14098. Epub 2018 Jul 13.

PMID:
30005132
36.

Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant.

Badawy A, Kaido T, Atsushi Y, Yagi S, Hata K, Kamo N, Fukumitsu K, Okajima H, Uemoto S.

Exp Clin Transplant. 2018 Jun 18. doi: 10.6002/ect.2018.0005. [Epub ahead of print]

37.

Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?

Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S.

Prog Transplant. 2018 Sep;28(3):213-219. doi: 10.1177/1526924818781571. Epub 2018 Jun 14.

PMID:
29902957
38.

Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.

Ganbaatar B, Fukuda D, Salim HM, Nishimoto S, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Sata M.

Atherosclerosis. 2018 Aug;275:124-132. doi: 10.1016/j.atherosclerosis.2018.05.053. Epub 2018 May 31.

PMID:
29902700
39.

Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience.

Aliyev V, Yagi S, Hammad A, Badawy A, Sasaki Y, Masano Y, Yamamoto G, Kamo N, Taura K, Okajima H, Kaido T, Uemoto S.

Ann Hepatobiliary Pancreat Surg. 2018 May;22(2):144-149. doi: 10.14701/ahbps.2018.22.2.144. Epub 2018 May 30.

40.

Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma.

Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S.

Liver Cancer. 2018 May;7(2):179-189. doi: 10.1159/000487058. Epub 2018 Mar 1.

41.

The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation.

Badawy A, Kaido T, Hammad A, Yagi S, Kamo N, Yoshizawa A, Okajima H, Uemoto S.

World J Surg. 2018 Dec;42(12):4081-4089. doi: 10.1007/s00268-018-4696-5.

PMID:
29882099
42.

Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.

Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2018 Aug 24;82(9):2253-2258. doi: 10.1253/circj.CJ-17-0758. Epub 2018 May 30.

43.

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M.

Circ J. 2018 Jun 25;82(7):1778-1787. doi: 10.1253/circj.CJ-18-0021. Epub 2018 May 25.

44.

Genomic Epidemiology Reconstructs the Introduction and Spread of Zika Virus in Central America and Mexico.

Thézé J, Li T, du Plessis L, Bouquet J, Kraemer MUG, Somasekar S, Yu G, de Cesare M, Balmaseda A, Kuan G, Harris E, Wu CH, Ansari MA, Bowden R, Faria NR, Yagi S, Messenger S, Brooks T, Stone M, Bloch EM, Busch M, Muñoz-Medina JE, González-Bonilla CR, Wolinsky S, López S, Arias CF, Bonsall D, Chiu CY, Pybus OG.

Cell Host Microbe. 2018 Jun 13;23(6):855-864.e7. doi: 10.1016/j.chom.2018.04.017. Epub 2018 May 24.

45.

NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population.

Nishida N, Aiba Y, Hitomi Y, Kawashima M, Kojima K, Kawai Y, Ueno K, Nakamura H, Yamashiki N, Tanaka T, Tamura S, Mori A, Yagi S, Soejima Y, Yoshizumi T, Takatsuki M, Tanaka A, Harada K, Shimoda S, Komori A, Eguchi S, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2018 May 23;8(1):8071. doi: 10.1038/s41598-018-26369-6.

46.

Introduction of Mesenchymal Stem Cells for Liver Surgery (Hepatectomy and Transplantation).

Uemoto S, Fujimoto Y, Teratani T, Kanazawa H, Iwasaki J, Xiangdong Z, Masano Y, Yagi S, Hata K, Kobayashi E.

In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015.

47.

Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation.

Kamo N, Kaido T, Hamaguchi Y, Uozumi R, Okumura S, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S.

World J Surg. 2018 Nov;42(11):3715-3725. doi: 10.1007/s00268-018-4680-0.

PMID:
29785692
48.

Experimental Zika Virus Infection in the Pregnant Common Marmoset Induces Spontaneous Fetal Loss and Neurodevelopmental Abnormalities.

Seferovic M, Sánchez-San Martín C, Tardif SD, Rutherford J, Castro ECC, Li T, Hodara VL, Parodi LM, Giavedoni L, Layne-Colon D, Tamhankar M, Yagi S, Martyn C, Reyes K, Suter MA, Aagaard KM, Chiu CY, Patterson JL.

Sci Rep. 2018 May 1;8(1):6851. doi: 10.1038/s41598-018-25205-1. Erratum in: Sci Rep. 2018 Oct 26;8(1):16131.

49.

Is Portal Venous Pressure Modulation Still Indicated for All Recipients in Living Donor Liver Transplantation?

Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S.

Liver Transpl. 2018 Nov;24(11):1578-1588. doi: 10.1002/lt.25180.

PMID:
29710397
50.

Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients.

Kusunose K, Okushi Y, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ J. 2018 Jul 25;82(8):2103-2110. doi: 10.1253/circj.CJ-18-0017. Epub 2018 Apr 28.

Supplemental Content

Support Center